Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice
Cancer Letters · 2023
DOI: 10.1016/j.canlet.2023.216155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Guangfu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China; Pancreas Institute, Nanjing Medical University, Nan…. Hauptthemen laut MEDLINE: Metformin, Carcinoma, Pancreatic Ductal, Extracellular Traps, Pancreatic Neoplasms. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Obesity has been linked to a higher risk of pancreatic cancer. However, the mechanism by which obesity promote pancreatic carcinogenesis is still unclear. We investigated the effect of obesity on pancreatic carcinogenesis in Pdx1-Cre; LSL-KrasG12D+/- (KC) mice. Metformin was administrated to rescue the effects of obesity and NETs. The pro-tumorigenic effects of neutrophil extracellular traps (NETs) were further evaluated in vivo and vitro. We found that obesity significantly promoted the progression of murine pancreatic ductal intraepithelial neoplasia (mPanIN). The proliferation rate and epithelial-mesenchymal transition (EMT) of mPanIN ductal cells were increased in obese mice. More visceral adipocytes, PD-L1+ neutrophil infiltration and NETs formation were found in the pancreas of obese mice and visceral adipocytes could recruit neutrophils and promote NETs formation. The latter could induce an inflammatory response in ductal cells via TLR4-dependent pathways both in vivo and vitro, as demonstrated by upregulation of IL-1β. Metformin and DNase I significantly reversed the pro-tumorigenic effects of obesity and NETs in vivo and in vitro. Our study provides causal evidence for the contribution of obesity in promoting pancreatic carcinogenesis in genetic model and reveals the mechanism by NETs to regulate mPanIN progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China; Pancreas Institute, Nanjing Medical University, Nanjing, 210000, China.
- Department of Pathology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
- Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China; Pancreas Institute, Nanjing Medical University, Nanjing, 210000, China; Pancreas Center, The Affiliated BenQ Hospital of…
- Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China; Pancreas Institute, Nanjing Medical University, Nanjing, 210000, China. Electronic address: surgeonmark@hotmail.com.
Zitieren
APA
Wang, G., Gao, H., Dai, S., Li, M., Gao, Y., Yin, L., Zhang, K., Zhang, J., Jiang, K., Miao, Y., & Lu, Z. (2023). Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216155
Vancouver
Wang G, Gao H, Dai S, Li M, Gao Y, Yin L, et al. Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216155
BibTeX
@article{Wang2023,
author = {Wang, Guangfu and Gao, Hao and Dai, Shangnan and Li, Mingna and Gao, Yong and Yin, Lingdi and Zhang, Kai and Zhang, Jingjing and Jiang, Kuirong and Miao, Yi and Lu, Zipeng},
title = {Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice},
journal = {Cancer Letters},
year = {2023},
doi = {10.1016/j.canlet.2023.216155}
}
EUVIMED